| 1st Jul 2019 7:16 am |
EQS |
Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value |
| 27th Jun 2019 7:00 am |
RNS |
Successful Litigation Settlement |
| 27th Jun 2019 7:00 am |
RNS |
Trading Statement |
| 19th Jun 2019 7:00 am |
RNS |
Board Change |
| 11th Jun 2019 7:00 am |
RNS |
Holdings in Company |
| 21st May 2019 7:15 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): House dust mite vaccine - clinical progress |
| 20th May 2019 7:00 am |
RNS |
Positive top line phase I results for Acarovac MPL |
| 14th May 2019 7:00 am |
RNS |
Holdings in Company |
| 13th May 2019 6:14 pm |
RNS |
Holding(s) in Company |
| 13th May 2019 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 13th May 2019 4:35 pm |
RNS |
Price Monitoring Extension |
| 7th May 2019 7:00 am |
RNS |
Research Published on Adjuvant Systems |
| 25th Apr 2019 7:00 am |
RNS |
Regulatory and Trading Update |
| 18th Mar 2019 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 18th Mar 2019 4:36 pm |
RNS |
Price Monitoring Extension |
| 18th Mar 2019 11:30 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Take an objective view |
| 18th Mar 2019 11:05 am |
RNS |
Second Price Monitoring Extn |
| 18th Mar 2019 11:00 am |
RNS |
Price Monitoring Extension |
| 18th Mar 2019 9:05 am |
RNS |
Second Price Monitoring Extn |
| 18th Mar 2019 9:00 am |
RNS |
Price Monitoring Extension |
| 18th Mar 2019 7:00 am |
RNS |
Top Line Phase III results from B301 trial |
| 6th Mar 2019 12:10 pm |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Strong operating performance driving market share |
| 6th Mar 2019 7:00 am |
RNS |
Interim Results |
| 17th Jan 2019 9:56 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Trading update: gaining market share |
| 16th Jan 2019 7:00 am |
RNS |
Trading Update & Notice of Results |
| 29th Nov 2018 5:59 pm |
RNS |
Holdings in Company |
| 27th Nov 2018 1:12 pm |
RNS |
Result of AGM |
| 27th Nov 2018 7:00 am |
RNS |
AGM Trading Update |
| 12th Nov 2018 12:00 pm |
RNS |
Presentation at Jefferies Healthcare Conference |
| 8th Nov 2018 7:00 am |
RNS |
Directorate Change |
| 7th Nov 2018 6:06 pm |
RNS |
Holdings in Company |
| 2nd Nov 2018 7:00 am |
RNS |
Grant of Awards under Long Term Incentive Plan |
| 24th Oct 2018 1:25 pm |
RNS |
Holdings in Company |
| 24th Oct 2018 7:00 am |
RNS |
Director/PDMR Shareholding |
| 23rd Oct 2018 5:29 pm |
RNS |
Annual Report and Accounts |
| 23rd Oct 2018 3:28 pm |
RNS |
Holdings in Company |
| 27th Sep 2018 7:15 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): 2018 full-year results: solid growth |
| 26th Sep 2018 7:00 am |
RNS |
Preliminary Results |
| 8th Aug 2018 7:00 am |
RNS |
Notice of Results |
| 27th Jul 2018 5:26 pm |
RNS |
Holding(s) in Company |
